Abattis Bioceuticals Corp. announced that the appointment of Robert Abenante and Peter Gordon to its Board of Directors. Mr. Abenante is the President and CEO of Abattis and its subsidiaries. He is a seasoned executive who has served as a board member and executive officer of several public and private companies. Mr. Abenantes experience spans across several industries, including energy, mining, finance, technology and nutraceuticals in several global public markets. Mr. Gordon, who has acted as a consultant for Abattis in the past, has enjoyed a distinguished career, assisting companies in navigating through licensing processes, urban development and resource and commodity rights applications at all levels of government, from municipal to federal In addition to owning licensed pharmacies, Mr. Gordon has also served as a board member of the Squamish Hospital Foundation and the Guissippe Garibaldi Foundation, and has served as a school board trustee. Mr. Abenante and Mr. Gordon replaced Guy Dancosse and Doug Sorocco. Mr. Dancosse and Mr. Sorocco were long serving members of the Board who have moved on to focus more attention on other ventures.